. 2009 Mar 23;11(2):R17. doi: 10.1186/bcr2241

Table 3.

Chemotherapy regimens used in the Clearview Cancer Institute in Huntsville and Roswell Park Cancer Institute cohorts

Regimen	Number
CCIH
AC	44
CAF	22
AC + pT	43
AC + dT	11
A + dT	7
CAF + pT	2
AC + pT + dT	2
CMF	72

RPCI
AC	17
AC + pT	33
AC + dT	12
pT^a	1
P + pT^a	1

Since the Roswell Park Cancer Institute (RPCI) cohort had more standardized treatment (97% had AC or AC + T), the two patients who did not receive AC as part of their regimen were filtered from the analysis. ^aPatients not included in the analysis. A, doxorubicin; AC, doxorubicin + cyclophosphamide; CAF, cyclophosphamide, doxorubicin, and 5-fluorouracil; CCIH, Clearview Cancer Institute in Huntsville; CMF, cyclophosphamide, methotrexate, and 5-fluorouracil; dT, docetaxel; P, carboplatin. pT, paclitaxel; T, taxane (paclitaxel or docetaxel).